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o r i g i n a l a r t i c l e
Assessment of Healthcare Worker Protocol Deviations and
Self-Contamination During Personal Protective Equipment
Donning and Dofﬁng
Jennie H. Kwon, DO, MSCI;1 Carey-Ann D. Burnham, PhD;2 Kimberly A. Reske, MPH;1 Stephen Y. Liang, MD, MPHS;1
Tiffany Hink, BS;1 Meghan A. Wallace, BS;2 Angela Shupe, BS;2 Sondra Seiler, BA;1 Candice Cass, AA;1
Victoria J. Fraser, MD;1 Erik R. Dubberke, MD, MSPH1 for the CDC Prevention Epicenters
objective. To evaluate healthcare worker (HCW) risk of self-contamination when donning and dofﬁng personal protective equipment
(PPE) using ﬂuorescence and MS2 bacteriophage.
design. Prospective pilot study.
setting. Tertiary-care hospital.
participants. A total of 36 HCWs were included in this study: 18 donned/doffed contact precaution (CP) PPE and 18 donned/doffed
Ebola virus disease (EVD) PPE.
interventions. HCWs donned PPE according to standard protocols. Fluorescent liquid and MS2 bacteriophage were applied to HCWs.
HCWs then doffed their PPE. After dofﬁng, HCWs were scanned for ﬂuorescence and swabbed for MS2. MS2 detection was performed using
reverse transcriptase PCR. The donning and dofﬁng processes were videotaped, and protocol deviations were recorded.
results. Overall, 27% of EVD PPE HCWs and 50% of CP PPE HCWs made ≥1 protocol deviation while donning, and 100% of EVD PPE
HCWs and 67% of CP PPE HCWs made ≥1 protocol deviation while dofﬁng (P= .02). The median number of dofﬁng protocol deviations
among EVD PPE HCWs was 4, versus 1 among CP PPE HCWs. Also, 15 EVD PPE protocol deviations were committed by dofﬁng assistants
and/or trained observers. Fluorescence was detected on 8 EVD PPE HCWs (44%) and 5 CP PPE HCWs (28%), most commonly on hands. MS2
was recovered from 2 EVD PPE HCWs (11%) and 3 CP PPE HCWs (17%).
conclusions. Protocol deviations were common during both EVD and CP PPE dofﬁng, and some deviations during EVD PPE dofﬁng were
committed by the HCW dofﬁng assistant and/or the trained observer. Self-contamination was common. PPE donning/dofﬁng are complex and
deserve additional study.
Infect Control Hosp Epidemiol 2017;38:1077–1083
Personal protective equipment (PPE) is used in healthcare
settings to protect healthcare workers (HCWs) from exposure
to pathogens and to prevent the spread of pathogens to other
patients. Proper use of PPE is crucial when HCWs care for
patients with highly pathogenic organisms, such as the Ebola
virus. To date, studies on PPE effectiveness are uncommon,
small, and potentially out of date, andmany evaluate PPE types
no longer in use.1 The 2014–2016 Ebola virus disease (EVD)
outbreak revealed the need for better empirical data regarding
best practices to safely don and doff PPE.1–5
Although EVD is a high-visibility, high-impact disease, HCWS
are much more likely to encounter pathogens on a daily basis,
including methicillin-resistant Staphylococcus aureus (MRSA),
vancomycin-resistant Enterococcus, Clostridium difﬁcile, and
carbapenem-resistant Enterobacteriaceae. The primary forms
of PPE used to protect HCWs and other patients against
these important hospital-associated pathogens are associated
with contact precautions (CP), which includes gown and
gloves. Few data exist regarding whether HCWs follow
guidelines for donning and dofﬁng CP PPE and their risk of
self-contamination.6,7
One of the primary challenges when designing studies to
evaluate PPE or donning/dofﬁng procedures is determining
how to model pathogen transmission. The most commonly
used surrogate marker for the presence of pathogens is ﬂuor-
escence, and it can be delivered in a variety of forms: powder,
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liquid, lotion, etc.7–14 Fluorescent markers are inexpensive,
easy to use, and because the read out is visual, they can provide
immediate feedback to HCWs; however, ﬂuorescence may not be
an appropriate surrogate for contamination with infectious viral
particles.10 An alternate marker for viral infection is the MS2
bacteriophage, a single-strand RNA bacteriophage that is a bio-
safety level 1 agent and nonpathogenic to humans. MS2 has been
used previously in several studies of PPE transmission and/or
disinfection,10,11,15,16 in a long-term-care facility,17 a hotel,18 and
an ofﬁce.19 Commercial preparations of MS2 are expensive and
require signiﬁcant laboratory expertise to use, but they may pro-
vide a more accurate surrogate marker for how pathogens spread
in the environment than ﬂuorescence.3,10
The purpose of this study was to evaluate HCW risk of self-
contamination when donning and dofﬁng EVD PPE and CP
PPE using MS2 bacteriophage and a ﬂuorescent marker as
surrogates for pathogen transmission. The frequencies and
types of protocol deviations that occurred were documented,
and associations between HCW self-contamination after
dofﬁng and particular dofﬁng protocol deviations or HCW
characteristics were determined.
methods
This prospective pilot study was performed at Barnes-Jewish
Hospital (BJH), a 1,250-bed, tertiary-care hospital in St Louis,
Missouri. The study was approved by the Washington
University Human Research Protection Ofﬁce, and all parti-
cipants provided written, informed consent. During the study
period, EVD PPE consisted of inner and outer gloves (Esteem
XP, Cardinal Health, Dublin OH), boot covers (Convertors
FullGuard High Top Shoe Covers, Cardinal Health), imper-
vious gown with Velcro on the back of the neck (Convertors
SmartSleeve, Cardinal Health), a powered air-purifying
respirator (PAPR) and hood with face shield (Versaﬂo, 3M,
Maplewood, MN), and an outer apron (Tyvek apron, Uline,
Pleasant Prairie, WI). CP PPE consisted of gloves and a gown
(Cardinal Health).
HCW Characteristics
Two sets of HCWs were enrolled in this study. EVD PPE
HCWs were enrolled during EVD PPE practice sessions and
included respiratory therapists, nurses, infection control pre-
ventionists, and critical care physicians. CP PPE HCWs were
recruited from BJH hospital wards during their normal shifts
and included nurses, patient care technicians, and physicians.
HCWs were interviewed regarding demographics and years of
service, previous PPE training; HCW height and weight were
measured and body mass index (BMI) was calculated.
PPE Donning and Dofﬁng and Contamination Procedures
During EVD PPE training sessions, the donning and dofﬁng
processes were aided by a donning/dofﬁng assistant and a
trained observer who instructed HCWs step-by-step as per
CDC guidelines.20 HCWs using CP PPE were not given don-
ning or dofﬁng instructions; they were encouraged to proceed
according to their usual practices.
After consent, participants were scanned for baseline
ﬂuorescence using an UV-A light. Any areas of ﬂuorescence
detected were cleaned and noted. Next, HCWs were instructed
to don the PPE. Upon completion, HCWs were instructed to
close their eyes, and the MS2 bacteriophage and ﬂuorescent
marker were applied to HCW palms, abdomens, and ankles
(for EVD PPE HCWs) or palms and abdomens (for CP PPE
HCWs). Dummy applications of molecular grade water were
applied to HCW shoulders. After donning, EVD PPE HCWs
practiced various EVD patient care activities before dofﬁng.
CP PPE HCWs proceeded directly to dofﬁng. The order and
technique used to don and doff the PPE were videotaped and
recorded. Immediately after dofﬁng, the participant was
scanned for ﬂuorescence. Any areas of ﬂuorescence detected
were photographed and sampled utilizing a ﬂocked swab in
universal transport medium (Quidel, San Diego, CA). HCW
hands (1 swab for both hands), coat sleeves or wrist, and
peri-orbital/nasal/oral areas were swabbed regardless of
ﬂuorescence.
Donning and dofﬁng videos were reviewed and protocol
deviations were recorded. A second reviewer randomly
reviewed selected videos to ensure accuracy. Protocol devia-
tions were grouped into categories based on site and the
donning/dofﬁng procedural step during which they occurred
(ie, glove removal and hand hygiene; PAPR and hood
removal). Proper CP PPE and EVD PPE removal sequence
were based on recommendations from the CDC6,20 and on
written protocols used by the BJH infection prevention team.
A commercially available preparation of MS2 (Zeptometrix,
Buffalo, NY), supplied as a stock solution of 1.0 × 109 PFU/mL,
was utilized as a surrogate for viral transmission. This substance
was diluted to a 1:10 solution in viral transport medium for a
working solution of 1.0 × 108 PFU/mL. GloGerm Mist liquid
was selected as the ﬂuorescent marker (GloGerm, Moab, UT).
A mixture of 100 µL GloGerm Mist liquid with 0.5mL working
solution MS2 was applied to each contamination site. This
combination was tested, and there was no negative effect on
MS2 recovery and detection. The mixture of GloGerm liquid
and MS2 was drawn into a 3-mL syringe with a needleless,
Luer-lock tip (Becton Dickinson, Franklin Lakes, NJ). The
syringe was attached to a pediatric intranasal laryngeal mask
airway mucosal atomization device (LMAMADNasal, Teleﬂex,
Westmeath, Ireland). Syringes were not reused.
MS2 RNA was extracted utilizing a QIAamp viral RNA mini
kit (Qiagen, Valencia, CA). MS2 detection was performed
using reverse-transcriptase polymerase chain reaction (PCR)
using previously described primers21 and the Cepheid Smart
Cycler with QuantiTect Probe RT-PCR Kit (Qiagen, Valencia,
CA). A positive control with MS2 RNA, and a negative control
of PCR water was included in each run. The cycle threshold for
all positive results was recorded.
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Statistical Analyses
The primary outcomes of interest were the presence and fre-
quency of MS2 and/or ﬂuorescent contamination on the HCW
after removal of PPE. The secondary endpoints were the cor-
relations of the presence of contamination with the number of
lapses in PPE dofﬁng techniques, years of experience, type of
PPE, and BMI. Univariate analyses were performed, and
P ≤ .05 was considered signiﬁcant. We used χ2 or univariate
logistic regression for categorical variables, and we used the
Mann-Whitney test for continuous variables. Analyses were
performed with SPSS version 24 (IBM, Armonk, NY).
results
In total, 36 HCWs were enrolled in the study: 18 with EVD
PPE and 18 with CP PPE. Most HCWs were nurses: 78% of
EVD PPE HCWs and 61% of CP PPE HCWs (Table 1). EVD
PPE HCWs were signiﬁcantly older than CP PPE HCWs
(median age, 38 vs 28.5 years; P= .02), and there was a trend
toward greater years of service among the EVD PPE HCWs
(median years of service, 8.5 vs 5.25; P= .10).
Donning and Dofﬁng Protocol Deviations
Donning videos were available for review for 15 EVD PPE
HCWs (Table 2). Donning videos for the remaining 3 HCWs
were unavailable because the HCW was donning simulta-
neously while another HCWwas being recorded. Overall, 27%
of EVD PPE HCWs made at least 1 donning protocol devia-
tion, compared with 50% of CP PPEHCWs (P= .28). Protocol
deviations occurred most often in the gloves and hand-hygiene
steps (20% of EVD PPE HCWs and 33% of CP PPE HCWs).
All EVD PPE HCWs had at least 1 dofﬁng protocol
deviation, versus 67% of CP PPE HCWs (P= .02) (Table 2).
The median number of dofﬁng protocol deviations was greater
among EVD PPE HCWs (median, 4 vs 1 among CP PPE
HCWs). Moreover, 15 protocol deviations during EVD PPE
dofﬁng were committed by the dofﬁng assistant or trained
observer: 6 during gown or apron removal, 2 involving hand
hygiene, 2 during hood removal, 2 during boot-cover removal,
1 during PAPR removal, and 2 miscellaneous deviations.
Among EVD PPE HCWs, the unique dofﬁng step with the
greatest number of protocol deviations was boot-cover
removal: 78% of HCWs made at least 1 protocol deviation
dofﬁng boot covers. The dofﬁng step category with the greatest
number of HCWs that committed at least 1 protocol deviation
(in both PPE types) was gown/apron removal (83% of EVD
PPE HCWs; 50% of CP PPE HCWs), followed by glove
removal/hand hygiene (67% of EVD PPE HCWs; 39% of CP
PPE HCWs).
MS2 and Fluorescence
Overall, ﬂuorescence was detected on 8 EVD PPE HCWs
(44%) and 5 CP PPE HCWs (28%) (P= .49), and 21 unique
HCW sites ﬂuoresced. The most common site of ﬂuorescence
was HCW hands: 6 among EVD PPE HCWs and 5 among CP
PPE HCWs (Table 3). Of the 125 samples tested for MS2,
5 were positive (4%). MS2 was recovered from 2 EVD PPE
HCWs (11%) and 3 CP PPE HCWs (17%). The 2 EVD PPE
HCW sites from which MS2 was recovered were from an
alcohol foam pump in the dofﬁng area and an HCW’s hands
(Table 3). The 3 CP PPE HCW sites from which MS2 was
recovered were from the face of 1 HCW and from the sleeves/
wrist of 2 HCWs. Among the 5 sites positive for MS2, 2 (40%)
also ﬂuoresced. The association between ﬂuorescence and
dofﬁng protocol deviations is given in Table 4. There were no
signiﬁcant differences in detection of any ﬂuorescence by
protocol deviation type, although there was a trend toward
table 1. Healthcare Worker Demographics
Characteristic
Ebola PPE HCW
(n= 18), No. (%)a
Contact Precautions PPE HCW
(n= 18), No. (%)a P
Age, median (range) 38 (27–55) 28.5 (24–61) .02
Female 15 (83) 15 (83) 1.00
Years of service, median (range) 8.5 (2.5–30) 5.25 (<1–30) .10
Previous PPE training 17 (94) 13 (72) .18
HCW type
RN, PA, or NP 14 (78) 11 (61) Ref
MD 2 (11) 2 (11) .82
Other 2 (11) 5 (28) .21
Left handed 3 (17) 1 (6) .60
Body mass index
Normal 7 (39) 6 (33) Ref
Overweight 8 (44) 5 (28) .69
Obese 3 (17) 7 (39) .26
NOTE. PPE, personal protective equipment; HCW, healthcare worker; RN, registered nurse, PA, physician’s assistant; NP,
nurse practitioner; MD, medical doctor.
aUnless otherwise speciﬁed.
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signiﬁcance with boot-cover removal (100% of EVD PPE
HCWs with ﬂuorescence detected had a boot cover protocol
deviation, versus 60% of EVD PPE HCWs without ﬂuores-
cence; P= .09).
HCW Characteristics and Donning/Dofﬁng Protocol Deviations
Among EVD PPE HCWs, there was no signiﬁcant difference in
the median number of donning or dofﬁng protocol deviations
by years of service (data not shown). There were no signiﬁcant
differences in ﬂuorescence and/or MS2 detection between BMI
categories (ie, normal, overweight, or obese; data not shown).
There also were no signiﬁcant differences in the frequencies of
types of donning or dofﬁng protocol deviations by BMI (data
not shown).
discussion
Proper use of PPE is essential to protecting patients and HCWs
from infectious diseases. However, our results indicate that
protocol deviations were common in both donning and doff-
ing. Notably, we found that 100% of EVD PPE HCWs com-
mitted at least 1 protocol deviation during dofﬁng, and 27%
while donning. This ﬁnding is not surprising, given the com-
plexity of EVD PPE, and it is consistent with previous
studies.8,14,22 In a study involving 120 students, Casalino et al22
found that EVD PPE dofﬁng errors occurred even after a
3-phase training program. While protocol deviations while
dofﬁng are a major focus for HCW self-contamination, don-
ning deviations, such as an improperly tied gown (a deviation
we observed) may increase the future risk of self-
contamination while dofﬁng. Furthermore, we demonstrated
that not all protocol deviations were committed by the don-
ning and dofﬁng HCW. For example, several dofﬁng assistants
touched the inside of HCW gowns when undoing the neck
Velcro, and trained observers occasionally failed to instruct
HCWs to perform hand hygiene. While previous studies have
evaluated HCW protocol deviations while dofﬁng PPE, few
have evaluated the role of other HCWs in the dofﬁng process.
This is an important area for future investigation.
Boot-cover removal was particularly problematic. HCWs
received varied instructions on the speciﬁcs of the boot-cover
removal process. HCWs struggled to balance their legs in the
air or rest their legs on their scrubs without contaminating
themselves, and left-handed HCWs struggled to use right-
handed scissors. All 3 left-handed EVD PPE HCWs made ≥1
table 2. Donning and Dofﬁng Protocol Deviations by Personal







(n= 18), No. (%)a
Donning
Anyc 4 (27) 9 (50)
Gloves/Hand hygiene 3 (20) 6 (33)
Gown/Apron 3 (20) 4 (22)
PAPR/Hood 2 (13) N/A
Other 1 (7) 0 (0)
No. of protocol deviations,
median (range)
0 (0–4) 0.5 (0–2)
Dofﬁng
Anyd 18 (100) 12 (67)
Boot-cover removal 14 (78) N/A
Gloves/Hand hygiene 12 (67) 7 (39)
Gown/Apron 15 (83) 9 (50)
PAPR/Hood 7 (39) N/A
Shoe disinfection 8 (44) N/A
Other 2 (11) 0 (0)
No. of protocol deviations,
median (range)
4 (2–8) 1 (0–2)
NOTE. HCW, healthcare worker; N/A, not applicable; PAPR, powered
air-purifying respirator.
aUnless otherwise speciﬁed.
bn= 18 and n= 15 for donning; donning videos were available for 15
of 18 EVD PPE HCWs.
cP= .28.
dP= .02.
table 3. Sites of Fluorescence and/or MS2 (N= 24)a by
PPE Type
















NOTE. PPE, personal protective equipment; EVD, Ebola virus disease;
HCW, healthcare worker.
a6 HCWs had >1 site of ﬂuorescence (none had >1 site of MS2).
b6 were ﬂuorescent; 1 was MS2 positive.
c1 ﬂuorescent only; 1 ﬂuorescent and MS2 positive.
dMS2 positive only.
eFluorescent and MS2 positive.







Any 12 (92) 18 (78)
Boot-cover removalc 8 (100) 6 (60)
Gloves/Hand hygiene 8 (62) 11 (48)
Gown/Apron 10 (77) 14 (61)
PAPR/Hooda 3 (38) 4 (40)
Shoe disinfectiona 5 (63) 3 (30)
Other 0 (0) 2 (9)
an= 13; n= 8 among EVD PPE HCWs.
bn= 23; n= 10 among EVD PPE HCWs.
cAmong EVD PPE HCWs only (n= 18).
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protocol deviation during boot-cover removal. Many HCWs
touched their scrubs with their shoes or gown, both potentially
contaminated, during boot-cover removal and shoe disinfec-
tion. Herlihey et al23 also reported difﬁculties with shoe-cover
removal. HCWs caring for EVD patients may be exposed to
large amounts of environmental contamination;3 thus, this
component of EVD PPE removal may beneﬁt from process
improvement. Notably, the recommendations for boot-cover
removal have changed since this study was performed. At BJH,
the revised process doffs gowns before boot covers, eliminates
the use of scissors, and allows HCWs to keep their feet on the
ground. We hypothesize that these changes will decrease pro-
tocol deviations, but more studies are needed to conﬁrm this.
Hand hygiene and glove removal protocol deviations were
common during dofﬁng of both EVD and CP PPE (67% and
39% of HCWs made ≥1 error, respectively). During EVD PPE
dofﬁng, common protocol deviations included touching outer
gloves with inner gloved hands and touching the outside of gloves
with bare hands. Herlihey et al23 reported similar challenges
dofﬁngmultiple pairs of gloves. Casanova et al15 comparedHCW
self-contamination after dofﬁng PPE with single gloves versus
double gloves, using MS2 as a marker, and found that although
double gloves reduced viral transfer, MS2 was still recovered
from the hands of 23% of HCWs after dofﬁng. These results may
not be directly comparable to our study because it is unclear
whether those HCWs performed hand hygiene after dofﬁng.
Regardless, hand hygiene and glove removal are high-risk
opportunities for HCW self-contamination. For both the EVD
and CP groups, we found ﬂuorescence on HCW hands more
often than any other site. HCWs may beneﬁt from targeted
training in the correct method for glove removal during EVD
PPE dofﬁng, and training should reinforce the fact that gloves are
not a substitute for proper hand hygiene.
Measures to reduce HCW self-contamination rates include
training and maintenance of training. Several previous studies
have suggested that, regardless of PPE type, increased training
and access to published donning/dofﬁng guidelines improves
HCWs’ ability to don and doff PPE without protocol devia-
tion.7,12,22,24,25 All EVD PPE HCWs in our study previously had
received formal EVD PPE training. By contrast, although 72% of
CP PPE HCWs reported having previous training in PPE don-
ning/dofﬁng, this training was often informal, “on the job”
training from other HCWs. Similarly, Turnberg et al26 reported
that 15%–40% of HCWs had not received PPE training during
the previous 12 months, and John et al27 found that “on the job”
training was the most common method of PPE training for
HCWs. Despite the comparative simplicity of the CP PPE don-
ning/dofﬁng process, only half of the HCWs were able to don
PPE without protocol deviation, and only approximately one-
third were able to doff PPE without protocol deviation. Common
CP PPE dofﬁng protocol deviations included touching the front
of the gown with bare hands or allowing the contaminated gown
to brush against scrubs while disposing. Possibly, HCWs may be
unaware that speciﬁc guidelines exist for donning/dofﬁng CP
precautions.6 Beam et al8 demonstrated that simple exposure to a
poster showing the correct donning/dofﬁng sequence may not be
enough to improve HCW practices. Tomas et al7 found that a
training session on CP PPE dofﬁng techniques led to a signiﬁcant
decrease in HCW self-contamination. Formal, targeted inter-
ventions or education programs may be needed to improve
CP PPE donning/dofﬁng practices.
We were unable to demonstrate clear superiority of either
surrogate marker. Fluorescence was detected more frequently
than MS2. MS2 was not detected from most sites with ﬂuores-
cence, and MS2 was detected from 3 sites without ﬂuorescence.
Commercial preparations ofMS2 are expensive; thus, ﬂuorescent
markers, which are inexpensive, may be preferable. Conversely,
Casanova et al10 found considerable MS2 transfer to HCWhands
and scrubs in the absence of ﬂuorescence; thus, ﬂuorescence may
not accurately mimic transmission of viral particles. MS2 is not
visible to the naked eye, and it is possible in our study that
additional areas of MS2 contamination were not detected
because, outside of HCWhands, face, and arms, we sampled only
those areas that ﬂuoresced. Additional data are needed on the
relative beneﬁts and limitations of these surrogate markers.
This study has several limitations. It was a relatively small
pilot study and as such was underpowered. The small number
of HCWs may not be reﬂective of HCW populations at large.
The methods need replication in larger studies, and our
methods and results may be useful in designing these. The end
of the 2014–2015 EVD outbreak may remove the impetus for
healthcare facilities to continue EVD PPE training programs,
potentially making future studies of HCWs using EVD PPE
more challenging. Some EVD PPE dofﬁng recommendations
have been revised since this study was performed. CP PPE,
however, are routinely used in healthcare facilities, and larger
studies may be possible. We used PCR for MS2 detection;
therefore, MS2 detection may not be reﬂective of viable MS2.
In conclusion, PPE are critical for protecting both HCWs and
patients from pathogens, regardless of whether the pathogen in
question is high impact like EVD or commonly encountered like
C. difﬁcile. Previously published data on donning and dofﬁng
EVD PPE are limited, both by the number of studies available
and the types of data and analyses.1,4 There are even fewer data on
donning and dofﬁng CP PPE. Our study highlights some
potential areas for future research, including an improved boot-
cover removal process, improved HCW education in the correct
processes for glove removal, and an overall need for better
training in the use of CP PPE. Both ﬂuorescent markers andMS2
can be used safely as surrogates for pathogen transmission,
although the relative strengths of each need further evaluation.
Overall, improved processes for donning/dofﬁng PPE and
improved methods for evaluated these processes will help to
protect both HCWs and patients from exposure to pathogens.
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